Lidocaine Hydrochloride
- Product NDC
- 50102-400
- 11-digit product format
- 501020400
- Labeler code
- 50102
- Product ID
- 50102-400_0d93c3cd-c678-4304-8bfd-47a9c529c6f8
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- lidocaine hydrochloride
- Dosage form
- INJECTION
- Route
- INFILTRATION; PERINEURAL
- Labeler
- Afaxys Pharma LLC
- Application
- ANDA215132
- Marketing category
- ANDA
- Marketing start
- 2022-06-29
- Marketing end
- 0000-00-00
- Substance
- LIDOCAINE HYDROCHLORIDE
- Active strength
- 10 mg/mL
- Pharmacologic classes
- Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 50102-400 | LIDOCAINE HYDROCHLORIDE INJECTION [AFAXYS PHARMA LLC] | 7 | Legacy NDC | 20250120_b54f5334-cdf1-8a22-e053-2995a90ad6da.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 50102-400-10 | 50102040010 | 10 VIAL, MULTI-DOSE in 1 TRAY (50102-400-10) > 20 mL in 1 VIAL, MULTI-DOSE (50102-400-01) | 2022-06-29 | 0000-00-00 | No | No | Current |